# Double Muscling in Cattle: Genes, Husbandry, Carcasses and Meat

**Authors:** Leo O. Fiems

PMC · DOI: 10.3390/ani2030472 · Animals : an Open Access Journal from MDPI · 2012-09-20

## TL;DR

Double-muscled cattle have more muscle and lean meat due to a myostatin gene mutation, but require special care for health and meat quality.

## Contribution

This paper reviews the genetic, physiological, and meat quality characteristics of double-muscled cattle and their implications for husbandry.

## Key findings

- Inactivation of the myostatin gene leads to increased muscle growth and high carcass yield in cattle.
- Double-muscled cattle have lower organ mass and are more prone to health issues like respiratory disease and dystocia.
- Meat from double-muscled cattle is leaner with a healthier fatty acid profile but may not always be more tender.

## Abstract

Selection for an increased meatiness in beef cattle has resulted in double-muscled (DM) animals, owing to the inactivation of the myostatin gene. These animals are characterized by an excellent conformation and an extremely high carcass yield, coinciding with a reduced organ mass. As a consequence, voluntary feed intake is reduced, but feed efficiency is considerably improved, although maintenance requirements are not clearly reduced. DM animals are more susceptible to respiratory disease, stress and dystocia, requiring extra attention for accommodation and welfare. Carcasses of DM animals are very lean, and intramuscular fat content is low. The fatty acid profile is different when compared with non-DM animals, containing less saturated fatty acids. Collagen content of the meat is lower, so that meat from double-muscled animals is mostly more tender. However, meat tenderness, color and juiciness are not always improved. A different metabolism as a consequence of faster glycolytic myofibers can be partly responsible for this phenomenon. DM animals are interesting for the producer and butcher, and beneficial for the consumer, if an appropriate nutrition and accommodation, and adequate slaughter conditions are taken into account.

Molecular biology has enabled the identification of the mechanisms whereby inactive myostatin increases skeletal muscle growth in double-muscled (DM) animals. Myostatin is a secreted growth differentiation factor belonging to the transforming growth factor-β superfamily. Mutations make the myostatin gene inactive, resulting in muscle hypertrophy. The relationship between the different characteristics of DM cattle are defined with possible consequences for livestock husbandry. The extremely high carcass yield of DM animals coincides with a reduction in the size of most vital organs. As a consequence, DM animals may be more susceptible to respiratory disease, urolithiasis, lameness, nutritional stress, heat stress and dystocia, resulting in a lower robustness. Their feed intake capacity is reduced, necessitating a diet with a greater nutrient density. The modified myofiber type is responsible for a lower capillary density, and it induces a more glycolytic metabolism. There are associated changes for the living animal and post-mortem metabolism alterations, requiring appropriate slaughter conditions to maintain a high meat quality. Intramuscular fat content is low, and it is characterized by more unsaturated fatty acids, providing healthier meat for the consumer. It may not always be easy to find a balance between the different disciplines underlying the livestock husbandry of DM animals to realize a good performance and health and meat quality.

## Linked entities

- **Genes:** LOC5521725 (growth/differentiation factor 8) [NCBI Gene 5521725]
- **Diseases:** respiratory disease (MONDO:0005087), urolithiasis (MONDO:0024647), dystocia (MONDO:0006737)

## Full-text entities

- **Genes:** MSTN (myostatin) [NCBI Gene 281187] {aka GDF8}, Smad3 (SMAD family member 3) [NCBI Gene 17127] {aka Madh3}, Igfbp2 (insulin-like growth factor binding protein 2) [NCBI Gene 16008] {aka IBP-2, Igfbp-2, mIGFBP-2}, MYF5 (myogenic factor 5) [NCBI Gene 281335], BMP [NCBI Gene 281024], Mb (myoglobin) [NCBI Gene 17189], CAST (calpastatin) [NCBI Gene 281039], CTSD (cathepsin D) [NCBI Gene 282883] {aka CATD}, IGFBP1 (insulin like growth factor binding protein 1) [NCBI Gene 282259], INS (insulin) [NCBI Gene 280829], BMP4 (bone morphogenetic protein 4) [NCBI Gene 407216], MYF6 (myogenic factor 6) [NCBI Gene 281336] {aka MRF4}, Ppargc1a (peroxisome proliferative activated receptor, gamma, coactivator 1 alpha) [NCBI Gene 19017] {aka A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1}, Myog (myogenin) [NCBI Gene 17928] {aka MYF4, bHLHc3, myo}, MYOD1 (myogenic differentiation 1) [NCBI Gene 281938] {aka MyoD}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 338446] {aka PPARGC-1A}, MB (myoglobin) [NCBI Gene 280695] {aka GLNG}, SMAD7 (SMAD family member 7) [NCBI Gene 535916], SMAD2 (SMAD family member 2) [NCBI Gene 516010], IGF2 (insulin like growth factor 2) [NCBI Gene 281240], BMP7 (bone morphogenetic protein 7) [NCBI Gene 540595], Mstn (myostatin) [NCBI Gene 17700] {aka Cmpt, Gdf8}, Gh (growth hormone) [NCBI Gene 14599] {aka Gh1, Ghb1}, PARK7 (Parkinsonism associated deglycase) [NCBI Gene 511268] {aka DJ-1, DJ1}, NODAL (nodal growth differentiation factor) [NCBI Gene 530748], IGFI (Insulin-like growth factor 1 level) [NCBI Gene 104978413], Igfbp5 (insulin-like growth factor binding protein 5) [NCBI Gene 16011] {aka IGFBP-5, IGFBP-5P}, Park7 (Parkinson disease (autosomal recessive, early onset) 7) [NCBI Gene 57320] {aka DJ-1, Dj1}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 615037], Igfbp3 (insulin-like growth factor binding protein 3) [NCBI Gene 16009] {aka IGFBP-3, IGgfbp3}
- **Diseases:** miscarriage (MESH:D000022), Muscle hypertrophy (MESH:C536106), Parkinson's disease (MESH:D010300), congenital muscular dystonia I and II (MESH:D020821), lameness (MESH:D007794), calf loss (MESH:D048089), pneumonia (MESH:D011014), cancer (MESH:D009369), Muscling (MESH:D019042), DM (MESH:D005671), uterine adhesions (MESH:D014591), congenital defects (MESH:D000013), weight loss (MESH:D015431), urolithiasis (MESH:D052878), fatty (MESH:D008067), muscle degeneration (MESH:D009410), hereditary disorder (MESH:D009386), impaired (MESH:D060825), Locomotion (MESH:D020233), respiratory disease (MESH:D012140), bronchopneumonia (MESH:D001996), fiber damage (MESH:D000071075), Inflammation of the respiratory tract (MESH:D012141), hamartoma (MESH:D006222), BBDM (MESH:C537447), crooked tail syndrome (MESH:C536852), insulin resistance (MESH:D007333), coronary and heart diseases (MESH:D003327), abortion (MESH:D000026), Muscle fiber Type I (MESH:D006969), handicapped (MESH:D009422), dwarfism (MESH:D004392), hoof lesions (MESH:D009059), inflammation (MESH:D007249), hyperplasia (MESH:D006965), dystocia (MESH:D004420), alveolar hypoxia (MESH:D000860), respiratory disorders (MESH:D012131), fatigue (MESH:D005221), leg injuries (MESH:D007869), hypertrophy (MESH:D006984), Movement difficulties (MESH:D051346), urinary calculi (MESH:D014545), muscular dystrophy (MESH:D009136), muscle disease (MESH:D009135), arthrogryposis (MESH:D001176), tenderness (MESH:D063806), ruminal acidosis (MESH:D000079562), sudden death (MESH:D003645)
- **Chemicals:** ATP (MESH:D000255), cortisol (MESH:D006854), urea (MESH:D014508), lactate (MESH:D019344), BBDM (-), steroid hormones (MESH:D013256), PUFA (MESH:D005231), calcium phosphate (MESH:C020243), Non-esterified fatty acid (MESH:D005230), SDS (MESH:D012967), Glucose (MESH:D005947), n-3 PUFA (MESH:D015525), Oxygen (MESH:D010100), SFA (MESH:D005227), phospholipids (MESH:D010743), phosphorus (MESH:D010758), lipid (MESH:D008055), selenium (MESH:D012643), corticosterone (MESH:D003345), glycogen (MESH:D006003), hydroxyapatite (MESH:D017886), calcium (MESH:D002118)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Mesocricetus auratus (golden hamster, species) [taxon 10036], Equus caballus (domestic horse, species) [taxon 9796], Bos taurus (bovine, species) [taxon 9913]
- **Cell lines:** L6 — Mus musculus (Mouse), Hybridoma (CVCL_XK50), C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188), BeWo — Homo sapiens (Human), Gestational choriocarcinoma, Cancer cell line (CVCL_0044)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4494293/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC4494293/full.md

## References

217 references — full list in the complete paper: https://tomesphere.com/paper/PMC4494293/full.md

---
Source: https://tomesphere.com/paper/PMC4494293